{"organizations": [], "uuid": "8f8819f233741496a5e336a533cd22edabebcfd4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sage-therapeutics-announces-propos/brief-sage-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASB0C4JV", "country": "US", "domain_rank": 408, "title": "BRIEF-Sage Therapeutics Announces Proposed Public Offering Of Common Stock", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.145, "site_type": "news", "published": "2018-02-08T05:08:00.000+02:00", "replies_count": 0, "uuid": "8f8819f233741496a5e336a533cd22edabebcfd4"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sage-therapeutics-announces-propos/brief-sage-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASB0C4JV", "ord_in_thread": 0, "title": "BRIEF-Sage Therapeutics Announces Proposed Public Offering Of Common Stock", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sage therapeutics inc", "sentiment": "negative"}, {"name": "brief-sage therapeutics announces proposed public offering of common stock feb", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 7 (Reuters) - Sage Therapeutics Inc:\n* SAGE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* SAGE THERAPEUTICS INC - HAS COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $575.0 MILLION OF ITS COMMON STOCK\n* SAGE THERAPEUTICS - ALSO INTENDS TO GRANT UNDERWRITERS 30-DAY OPTION TO BUY UP TO AN ADDITIONAL $86.3 MILLION OF COMMON STOCK OFFERED IN PUBLIC OFFERING Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T05:08:00.000+02:00", "crawled": "2018-02-09T05:50:32.062+02:00", "highlightTitle": ""}